Skip to content

    Recently Viewed

      Listening...

      Home / Media Center / Press releases / Financial /
      Johnson & Johnson to Participate in the 2018 Deutsche Bank 43rd Annual Health Care Conference

      Johnson & Johnson to Participate in the 2018 Deutsche Bank 43rd Annual Health Care Conference

      Share Article
      share to

      New Brunswick, NJ (Apr. 24, 2018) -- Johnson & Johnson (NYSE: JNJ) will participate in the 2018 Deutsche Bank 43rd Annual Health Care Conference on Wednesday, May 9th, at The InterContinental Boston. Mathai Mammen, MD, Ph.D., Global Head, Research & Development, Janssen Research and Development will represent the Company in a session scheduled at 9:20 a.m. (Eastern Time).

      This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

      A webcast and podcast replay will be available approximately two hours after the live webcast.

      Press Contacts:
      Ernie Knewitz
      (732) 524-6623
      (917) 697-2318 (M)

      Cristal Downing
      (732) 524-3283
      (908) 616-8833 (M)

      Investor Contacts:
      Joseph J. Wolk
      (732) 524-1142

      Lesley Fishman
      (732) 524-3922

      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.